ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,537,152 | -20.4% | 400,300 | -0.0% | 0.00% | -50.0% |
| Q3 2022 | $1,930,000 | -40.2% | 400,400 | -1.4% | 0.00% | 0.0% |
| Q2 2022 | $3,228,000 | -28.0% | 406,102 | +33.0% | 0.00% | -33.3% |
| Q1 2022 | $4,484,000 | -26.8% | 305,246 | +0.7% | 0.00% | -25.0% |
| Q4 2021 | $6,126,000 | -22.7% | 303,234 | +3.9% | 0.00% | -20.0% |
| Q3 2021 | $7,925,000 | +10.3% | 291,805 | -1.1% | 0.01% | 0.0% |
| Q2 2021 | $7,187,000 | +34.1% | 295,163 | +34.5% | 0.01% | +25.0% |
| Q1 2021 | $5,358,000 | -21.4% | 219,499 | +3.1% | 0.00% | -20.0% |
| Q4 2020 | $6,817,000 | -3.6% | 212,974 | -0.7% | 0.01% | -16.7% |
| Q3 2020 | $7,072,000 | -1.3% | 214,380 | +40.0% | 0.01% | 0.0% |
| Q2 2020 | $7,166,000 | – | 153,087 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $40,911,000 | 7.12% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $36,944,000 | 3.67% |
| Burrage Capital Management LLC | 124,875 | $3,041,000 | 3.05% |
| Redmile Group, LLC | 7,522,029 | $183,161,000 | 2.71% |
| Indie Asset Partners, LLC | 91,641 | $2,231,000 | 1.81% |
| MPM BioImpact LLC | 218,027 | $5,309,000 | 0.87% |
| Ikarian Capital, LLC | 300,000 | $7,305,000 | 0.59% |
| Eventide Asset Management | 1,311,990 | $31,948,000 | 0.43% |
| Virtus ETF Advisers LLC | 21,540 | $524,000 | 0.22% |
| AlphaCentric Advisors LLC | 26,000 | $633,000 | 0.17% |